Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) FCF Margin (2019 - 2025)

Historic FCF Margin for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to 38.41%.

  • Pulmonx's FCF Margin fell 10200.0% to 38.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 35.54%, marking a year-over-year increase of 82800.0%. This contributed to the annual value of 39.37% for FY2024, which is 165700.0% up from last year.
  • Pulmonx's FCF Margin amounted to 38.41% in Q3 2025, which was down 10200.0% from 16.58% recorded in Q2 2025.
  • Pulmonx's FCF Margin's 5-year high stood at 16.58% during Q2 2025, with a 5-year trough of 144.55% in Q1 2022.
  • In the last 5 years, Pulmonx's FCF Margin had a median value of 64.67% in 2022 and averaged 65.61%.
  • As far as peak fluctuations go, Pulmonx's FCF Margin soared by 1016200bps in 2021, and later crashed by -370000bps in 2022.
  • Quarter analysis of 5 years shows Pulmonx's FCF Margin stood at 86.43% in 2021, then increased by 25bps to 64.67% in 2022, then soared by 31bps to 44.66% in 2023, then surged by 36bps to 28.79% in 2024, then crashed by -33bps to 38.41% in 2025.
  • Its FCF Margin stands at 38.41% for Q3 2025, versus 16.58% for Q2 2025 and 60.0% for Q1 2025.